*NURSING > ESSAY > NR 293 Week 6 Assignment: RUA: Medication Teaching Plan – Nurtec (ODT) | GRADED A (All)

NR 293 Week 6 Assignment: RUA: Medication Teaching Plan – Nurtec (ODT) | GRADED A

Document Content and Description Below

Nurtec ODT (Rimegepant) Chamberlain College of Nursing NR 293 – Pharmacology Rimegepant (Nurtec ODT) is a medication that was first approved by the FDA on February 27, 2020, to be used as a t... reatment for acute migraines (National Center for Biotechnology Information, 2020). Rimegepant is a calcitonin gene-related peptide receptor antagonist (CGRP), which is also referred to as gepants. Nurtec is the first CGRP to come in an orally disintegrating tablet but has drug interactions with CYP3A4 inhibitors, CYP3A inducers, and transporters. Rimegepant offers migraine relief to an expanded population when compared to triptans. Triptans constrict the blood vessels, which leaves a possibility for coronary artery construction as well. Since Nurtec does not have these properties, patients with hypertension or other heart-related problems are not contraindicated in this medication (Lipton, et al., 2020). Nurtec should be avoided in pregnant, breastfeeding patie [Show More]

Last updated: 1 year ago

Preview 1 out of 3 pages

Reviews( 0 )

$11.50

Add to cart

Instant download

Can't find what you want? Try our AI powered Search

OR

GET ASSIGNMENT HELP
35
0

Document information


Connected school, study & course


About the document


Uploaded On

Dec 15, 2022

Number of pages

3

Written in

Seller


seller-icon
A+ Solutions

Member since 3 years

164 Documents Sold


Additional information

This document has been written for:

Uploaded

Dec 15, 2022

Downloads

 0

Views

 35

Document Keyword Tags

Recommended For You


$11.50
What is Browsegrades

In Browsegrades, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.

We are here to help

We're available through e-mail, Twitter, Facebook, and live chat.
 FAQ
 Questions? Leave a message!

Follow us on
 Twitter

Copyright © Browsegrades · High quality services·